淋巴细胞白血病-话题@MedSci

#淋巴细胞白血病#

277篇内容 | 4748人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1997844, encodeId=9de0199e84488, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Lancet ：急性淋巴细胞白血病儿童患者——门东酰胺酶相关胰腺炎的毒性研究, objectType=article, longId=106289, objectId=2209106289d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2209106289d3, replyNumber=0, likeNumber=111, createdTime=2017-08-10, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2209106289d3, moduleTitle=Lancet ：急性淋巴细胞白血病儿童患者——门东酰胺酶相关胰腺炎的毒性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2209106289d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997850, encodeId=16f7199e850c4, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=NCCN临床实践指南：急性淋巴细胞白血病（2017.V3）, objectType=article, longId=113438, objectId=e0b31134383a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0b31134383a, replyNumber=0, likeNumber=28, createdTime=2017-11-12, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0b31134383a, moduleTitle=NCCN临床实践指南：急性淋巴细胞白血病（2017.V3）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0b31134383a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997830, encodeId=9bf8199e8307e, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=STM：通用CAR-T成功治疗2例B细胞急性淋巴细胞白血病, objectType=article, longId=88127, objectId=d4478812e0b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4478812e0b, replyNumber=0, likeNumber=74, createdTime=2017-08-29, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4478812e0b, moduleTitle=STM：通用CAR-T成功治疗2例B细胞急性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4478812e0b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997838, encodeId=3a6a199e83863, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=NAT GENET：超级基因图谱对抗凶险的T型急性淋巴细胞白血病, objectType=article, longId=104663, objectId=ab8610466311, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab8610466311, replyNumber=0, likeNumber=72, createdTime=2018-05-01, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab8610466311, moduleTitle=NAT GENET：超级基因图谱对抗凶险的T型急性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab8610466311)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997827, encodeId=e700199e827b9, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=2016NCCN临床实践指南：急性淋巴细胞白血病（2016.V2）发布, objectType=article, longId=80725, objectId=9ddd80e259b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ddd80e259b, replyNumber=0, likeNumber=35, createdTime=2017-08-15, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ddd80e259b, moduleTitle=2016NCCN临床实践指南：急性淋巴细胞白血病（2016.V2）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ddd80e259b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997839, encodeId=ade6199e839be, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=CLIN CANCER RES：CART19治疗难治/复发急性淋巴细胞白血病, objectType=article, longId=105025, objectId=6562105025ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6562105025ad, replyNumber=0, likeNumber=82, createdTime=2017-08-09, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6562105025ad, moduleTitle=CLIN CANCER RES：CART19治疗难治/复发急性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6562105025ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997837, encodeId=0401199e837ba, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：利用CAR T细胞治疗小儿急性淋巴细胞白血病的建议剂量和细胞处理方法, objectType=article, longId=103527, objectId=59f910352e50, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59f910352e50, replyNumber=0, likeNumber=74, createdTime=2018-04-01, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59f910352e50, moduleTitle=Blood：利用CAR T细胞治疗小儿急性淋巴细胞白血病的建议剂量和细胞处理方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59f910352e50)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997840, encodeId=9763199e840ce, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：Fc工程的CD19抗体可根除患者来源的MLL重排的急性淋巴细胞白血病移植瘤中的微小残留病灶。, objectType=article, longId=105339, objectId=424e10533925, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=424e10533925, replyNumber=0, likeNumber=61, createdTime=2017-07-25, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=424e10533925, moduleTitle=Blood：Fc工程的CD19抗体可根除患者来源的MLL重排的急性淋巴细胞白血病移植瘤中的微小残留病灶。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=424e10533925)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997831, encodeId=3ed1199e83100, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=J Clin Oncol：慢性淋巴细胞白血病：口服靶向药物治疗的经济负担, objectType=article, longId=95716, objectId=449995e16d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=449995e16d6, replyNumber=0, likeNumber=83, createdTime=2017-06-21, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=449995e16d6, moduleTitle=J Clin Oncol：慢性淋巴细胞白血病：口服靶向药物治疗的经济负担, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=449995e16d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997819, encodeId=a9be199e819c4, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=第4个适应症！诺华抗癌药Arzerra获FDA批准治疗复发性慢性淋巴细胞白血病（CLL）, objectType=article, longId=76568, objectId=80e0e6568b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80e0e6568b4, replyNumber=0, likeNumber=59, createdTime=2016-12-22, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80e0e6568b4, moduleTitle=第4个适应症！诺华抗癌药Arzerra获FDA批准治疗复发性慢性淋巴细胞白血病（CLL）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80e0e6568b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997829, encodeId=b504199e8298f, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=成年费城染色体阳性急性淋巴细胞白血病患者的疾病流行率与治疗效果调研, objectType=article, longId=83264, objectId=96fb832645e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96fb832645e, replyNumber=0, likeNumber=68, createdTime=2017-06-25, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96fb832645e, moduleTitle=成年费城染色体阳性急性淋巴细胞白血病患者的疾病流行率与治疗效果调研, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96fb832645e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997820, encodeId=c405199e82097, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=喜讯！FDA加速批准安进BiTE免疫疗法Blincyto治疗儿科Ph-急性淋巴细胞白血病（ALL）, objectType=article, longId=76569, objectId=1570e65698b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1570e65698b, replyNumber=0, likeNumber=77, createdTime=2017-08-18, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1570e65698b, moduleTitle=喜讯！FDA加速批准安进BiTE免疫疗法Blincyto治疗儿科Ph-急性淋巴细胞白血病（ALL）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1570e65698b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997825, encodeId=208d199e82578, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=2017NCCN临床实践指南——慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2017.V1）发布, objectType=article, longId=80032, objectId=b31a800321e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b31a800321e, replyNumber=0, likeNumber=34, createdTime=2017-04-13, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b31a800321e, moduleTitle=2017NCCN临床实践指南——慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2017.V1）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b31a800321e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997821, encodeId=a31e199e82184, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=2015培门冬酶治疗急性淋巴细胞白血病和恶性淋巴瘤中国专家共识发布, objectType=article, longId=76926, objectId=fc0ce69267e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc0ce69267e, replyNumber=0, likeNumber=28, createdTime=2016-10-06, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc0ce69267e, moduleTitle=2015培门冬酶治疗急性淋巴细胞白血病和恶性淋巴瘤中国专家共识发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc0ce69267e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997816, encodeId=ee8a199e816f1, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=第5个适应症！欧盟批准艾伯维突破性抗癌药Imbruvica一线治疗慢性淋巴细胞白血病（CLL）, objectType=article, longId=70030, objectId=0f9ae003001, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f9ae003001, replyNumber=0, likeNumber=79, createdTime=2016-06-07, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f9ae003001, moduleTitle=第5个适应症！欧盟批准艾伯维突破性抗癌药Imbruvica一线治疗慢性淋巴细胞白血病（CLL）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f9ae003001)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997817, encodeId=2b55199e81731, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=EHA 2016：辉瑞ADC药物inotuzumab ozogamicin治疗CD22阳性急性淋巴细胞白血病（ALL）表现出强劲疗效, objectType=article, longId=70650, objectId=3744e0650f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3744e0650f8, replyNumber=0, likeNumber=71, createdTime=2016-06-24, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3744e0650f8, moduleTitle=EHA 2016：辉瑞ADC药物inotuzumab ozogamicin治疗CD22阳性急性淋巴细胞白血病（ALL）表现出强劲疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3744e0650f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997823, encodeId=f3e5199e82318, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=2015ESMO恶性淋巴瘤共识会议建议——成熟的B细胞淋巴瘤和慢性淋巴细胞白血病的预测工具发布, objectType=article, longId=79904, objectId=d18ae9904b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d18ae9904b4, replyNumber=0, likeNumber=33, createdTime=2016-12-13, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d18ae9904b4, moduleTitle=2015ESMO恶性淋巴瘤共识会议建议——成熟的B细胞淋巴瘤和慢性淋巴细胞白血病的预测工具发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d18ae9904b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997818, encodeId=5a52199e818a2, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=2016 NCCN临床实践指南：急性淋巴细胞白血病（Version1.2016）, objectType=article, longId=72096, objectId=7b58e20966a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b58e20966a, replyNumber=0, likeNumber=47, createdTime=2017-01-16, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b58e20966a, moduleTitle=2016 NCCN临床实践指南：急性淋巴细胞白血病（Version1.2016）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b58e20966a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997828, encodeId=59db199e828d2, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=中国成人急性淋巴细胞白血病诊断与治疗指南（2016年版）, objectType=article, longId=81798, objectId=a8ee81e9863, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8ee81e9863, replyNumber=0, likeNumber=73, createdTime=2017-07-24, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8ee81e9863, moduleTitle=中国成人急性淋巴细胞白血病诊断与治疗指南（2016年版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8ee81e9863)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997826, encodeId=56c3199e82626, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=2016CCO实践指南：利妥昔单抗治疗淋巴瘤和慢性淋巴细胞白血病发布, objectType=article, longId=80524, objectId=8e848052465, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e848052465, replyNumber=0, likeNumber=33, createdTime=2017-09-09, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e848052465, moduleTitle=2016CCO实践指南：利妥昔单抗治疗淋巴瘤和慢性淋巴细胞白血病发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e848052465)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

淋巴细胞白血病

2020-05-29

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Lancet ：急性淋巴细胞白血病儿童患者——门东酰胺酶相关胰腺炎的毒性研究

2017-08-10

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

NCCN临床实践指南：急性淋巴细胞白血病（2017.V3）

2017-11-12

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

STM：通用CAR-T成功治疗2例B细胞急性淋巴细胞白血病

2017-08-29

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

NAT GENET：超级基因图谱对抗凶险的T型急性淋巴细胞白血病

2018-05-01

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

2016NCCN临床实践指南：急性淋巴细胞白血病（2016.V2）发布

2017-08-15

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

CLIN CANCER RES：CART19治疗难治/复发急性淋巴细胞白血病

2017-08-09

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：利用CAR T细胞治疗小儿急性淋巴细胞白血病的建议剂量和细胞处理方法

2018-04-01

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：Fc工程的CD19抗体可根除患者来源的MLL重排的急性淋巴细胞白血病移植瘤中的微小残留病灶。

2017-07-25

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

J Clin Oncol：慢性淋巴细胞白血病：口服靶向药物治疗的经济负担

2017-06-21

仁者大医 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

第4个适应症！诺华抗癌药Arzerra获FDA批准治疗复发性慢性淋巴细胞白血病（CLL）

2016-12-22

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

成年费城染色体阳性急性淋巴细胞白血病患者的疾病流行率与治疗效果调研

2017-06-25

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

喜讯！FDA加速批准安进BiTE免疫疗法Blincyto治疗儿科Ph-急性淋巴细胞白血病（ALL）

2017-08-18

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

2017NCCN临床实践指南——慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2017.V1）发布

2017-04-13

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

2015培门冬酶治疗急性淋巴细胞白血病和恶性淋巴瘤中国专家共识发布

2016-10-06

仁者大医 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

第5个适应症！欧盟批准艾伯维突破性抗癌药Imbruvica一线治疗慢性淋巴细胞白血病（CLL）

2016-06-07

仁者大医 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

EHA 2016：辉瑞ADC药物inotuzumab ozogamicin治疗CD22阳性急性淋巴细胞白血病（ALL）表现出强劲疗效

2016-06-24

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

2015ESMO恶性淋巴瘤共识会议建议——成熟的B细胞淋巴瘤和慢性淋巴细胞白血病的预测工具发布

2016-12-13

仁者大医 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

2016 NCCN临床实践指南：急性淋巴细胞白血病（Version1.2016）

2017-01-16

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

中国成人急性淋巴细胞白血病诊断与治疗指南（2016年版）

2017-07-24

一叶知秋 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

2016CCO实践指南：利妥昔单抗治疗淋巴瘤和慢性淋巴细胞白血病发布

2017-09-09

科室
- - 订阅+
  - 更多科室
工具
服务